Annual Cash & Cash Equivalents
$70.56 M
-$168.38 M-70.47%
December 31, 2024
Summary
- As of March 13, 2025, COLL annual cash & cash equivalents is $70.56 million, with the most recent change of -$168.38 million (-70.47%) on December 31, 2024.
- During the last 3 years, COLL annual cash & cash equivalents has fallen by -$115.86 million (-62.15%).
- COLL annual cash & cash equivalents is now -70.47% below its all-time high of $238.95 million, reached on December 31, 2023.
Performance
COLL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$70.56 M
+$31.61 M+81.12%
December 31, 2024
Summary
- As of March 13, 2025, COLL quarterly cash and cash equivalents is $70.56 million, with the most recent change of +$31.61 million (+81.12%) on December 31, 2024.
- Over the past year, COLL quarterly cash and cash equivalents has dropped by -$158.04 million (-69.13%).
- COLL quarterly cash and cash equivalents is now -75.13% below its all-time high of $283.75 million, reached on June 30, 2023.
Performance
COLL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
COLL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.5% | -69.1% |
| 3 y3 years | -62.1% | -72.7% |
| 5 y5 years | -58.5% | -72.7% |
COLL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.5% | at low | -75.1% | +81.1% |
| 5 y | 5-year | -70.5% | at low | -75.1% | +81.1% |
| alltime | all time | -70.5% | +4218.5% | -75.1% | +4218.5% |
Collegium Pharmaceutical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $70.56 M(-70.5%) | $70.56 M(+81.1%) |
| Sep 2024 | - | $38.96 M(-77.5%) |
| Jun 2024 | - | $172.89 M(-24.4%) |
| Mar 2024 | - | $228.61 M(-4.3%) |
| Dec 2023 | $238.95 M(+37.6%) | $238.95 M(-7.6%) |
| Sep 2023 | - | $258.53 M(-8.9%) |
| Jun 2023 | - | $283.75 M(+5.3%) |
| Mar 2023 | - | $269.48 M(+55.2%) |
| Dec 2022 | $173.69 M(-6.8%) | $173.69 M(+29.5%) |
| Sep 2022 | - | $134.13 M(+9.3%) |
| Jun 2022 | - | $122.72 M(+15.0%) |
| Mar 2022 | - | $106.70 M(-42.8%) |
| Dec 2021 | $186.43 M(+7.1%) | $186.43 M(-3.5%) |
| Sep 2021 | - | $193.24 M(-4.7%) |
| Jun 2021 | - | $202.77 M(+10.9%) |
| Mar 2021 | - | $182.79 M(+5.0%) |
| Dec 2020 | $174.12 M(+2.4%) | $174.12 M(+5.3%) |
| Sep 2020 | - | $165.42 M(+13.6%) |
| Jun 2020 | - | $145.68 M(+25.4%) |
| Mar 2020 | - | $116.18 M(-31.7%) |
| Dec 2019 | $170.02 M | $170.02 M(+10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $153.84 M(+3.4%) |
| Jun 2019 | - | $148.71 M(+10.2%) |
| Mar 2019 | - | $134.91 M(-8.0%) |
| Dec 2018 | $146.63 M(+23.5%) | $146.63 M(+4.9%) |
| Sep 2018 | - | $139.79 M(+4.5%) |
| Jun 2018 | - | $133.75 M(+4.3%) |
| Mar 2018 | - | $128.25 M(+8.0%) |
| Dec 2017 | $118.70 M(-22.5%) | $118.70 M(+10.3%) |
| Sep 2017 | - | $107.61 M(-3.2%) |
| Jun 2017 | - | $111.21 M(-14.2%) |
| Mar 2017 | - | $129.56 M(-15.4%) |
| Dec 2016 | $153.22 M(+60.1%) | $153.22 M(+68.3%) |
| Sep 2016 | - | $91.03 M(-17.8%) |
| Jun 2016 | - | $110.75 M(-17.8%) |
| Mar 2016 | - | $134.73 M(+40.8%) |
| Dec 2015 | $95.70 M(+5756.6%) | $95.70 M(-9.3%) |
| Sep 2015 | - | $105.46 M(-6.2%) |
| Jun 2015 | - | $112.41 M(+149.9%) |
| Mar 2015 | - | $44.99 M(+2653.3%) |
| Dec 2014 | $1.63 M(-78.4%) | $1.63 M |
| Dec 2013 | $7.55 M | - |
FAQ
- What is Collegium Pharmaceutical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical annual cash & cash equivalents year-on-year change?
- What is Collegium Pharmaceutical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Collegium Pharmaceutical?
- What is Collegium Pharmaceutical quarterly cash and cash equivalents year-on-year change?
What is Collegium Pharmaceutical annual cash & cash equivalents?
The current annual cash & cash equivalents of COLL is $70.56 M
What is the all time high annual cash & cash equivalents for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high annual cash & cash equivalents is $238.95 M
What is Collegium Pharmaceutical annual cash & cash equivalents year-on-year change?
Over the past year, COLL annual cash & cash equivalents has changed by -$168.38 M (-70.47%)
What is Collegium Pharmaceutical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of COLL is $70.56 M
What is the all time high quarterly cash and cash equivalents for Collegium Pharmaceutical?
Collegium Pharmaceutical all-time high quarterly cash and cash equivalents is $283.75 M
What is Collegium Pharmaceutical quarterly cash and cash equivalents year-on-year change?
Over the past year, COLL quarterly cash and cash equivalents has changed by -$158.04 M (-69.13%)